Zum Hauptinhalt springen
UB Hagen

Suchergebnisse

UB Katalog

Artikel & mehr
53 Treffer

Suchmaske

Suchtipp für den Bereich Artikel & mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur / Strichcode".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Gefunden in

Art der Quelle

Schlagwort

Verlag

Publikation

Sprache

53 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Predicting immunotherapy response and guiding combination therapy with Modulator of TMB-Associated Immune Infiltration MOTIF.
    In: Immunotherapy Weekly, 2024-04-02, S. 856-856
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H).
    In: Immunotherapy Weekly, 2024-04-09, S. 113-113
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    Studies Conducted at Department of Medical Oncology on Carcinomas Recently Published (Case report: Immunotherapy in rare high TMB pancreatic acinar carcinoma).
    In: Immunotherapy Weekly, 2024-03-26, S. 1323-1323
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    New Rectal Cancer Research from Cancer Hospital Outlined (Response to PD-1 inhibitor in SMARCB1-deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review).
    In: Immunotherapy Weekly, 2024-02-01, S. 663-663
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Research from EMD Serono Research & Development Institute Inc. Yields New Findings on Solid Cancer (Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays).
    In: Immunotherapy Weekly, 2023-10-31, S. 1118-1118
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    New Lung Cancer Findings from China-Japan Friendship Hospital Outlined (Correlation of Padi4, Gbp1, Mir-215, and Tmb Expression Levels With Clinical Characteristics and Prognosis of Lung Cancer).
    In: Cancer Weekly, 2023-09-12, S. 786-786
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    New T-Cell Lymphoma Study Findings Have Been Reported by Investigators at University of Jinan (Higher 13-gene-estimated Tmb Detected From Plasma Ctdna Is Associated With Worse Outcome for T-cell Lymphoma Patients).
    In: Cancer Weekly, 2023-09-26, S. 519-519
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    New Colon Cancer Research Has Been Reported by a Researcher at Sault Area Hospital [High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology].
    In: Immunotherapy Weekly, 2023-08-08, S. 464-464
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Study Findings from Zigong First People's Hospital Broaden Understanding of Colon Cancer (Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer).
    In: Cancer Weekly, 2023-06-13, S. 1301-1301
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy.
    In: Immunotherapy Weekly, 2024-05-27, S. 929-929
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Findings in Melanoma Reported from UPMC Hillman Cancer Center (Automated Quantitative Cd8+tumor-infiltrating Lymphocytes and Tumor Mutation Burden As Independent Biomarkers In Melanoma Patients Receiving Front-line Anti-pd-1 Immunotherapy).
    In: Immunotherapy Weekly, 2024-05-21, S. 810-810
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    New Cholangiocarcinoma Findings from Shinshu University Described (Intrahepatic Cholangiocarcinoma With High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly To Pembrolizumab but Perforated Within a Short Period).
    In: Immunotherapy Weekly, 2024-05-14, S. 816-816
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    New Breast Cancer Study Findings Have Been Reported from University of Southern California Keck School of Medicine (Evaluation of Markers of Immunity In Different Metastatic Immune Microenvironments Suggests More Suppression Within Breast To...).
    In: Women's Health Weekly, 2024-05-14, S. 712-712
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Studies from University of Texas Southwestern Medical Center Provide New Data on Cancer (Tissue-specific Thresholds of Mutation Burden Associated With Anti-pd-1/l1 Therapy Benefit and Prognosis In Microsatellite-stable Cancers).
    In: Cancer Weekly, 2024-04-16, S. 1312-1312
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Korea University Ansan Hospital Researcher Describes Research in Lung Cancer (Large-Scale Cancer Genomic Analysis Reveals Significant Disparities Between Microsatellite Instability and Tumor Mutational Burden).
    In: Immunotherapy Weekly, 2024-03-11, S. 635-635
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Studies Conducted at University of Texas Southwestern Medical Center Dallas on Lung Cancer Recently Reported (Loss of P53 and Mutational Heterogeneity Drives Immune Resistance In an Autochthonous Mouse Lung Cancer Model With High Tumor...).
    In: Immunotherapy Weekly, 2024-01-16, S. 564-564
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Researcher from U.S. Food and Drug Administration Details Findings in Cancer (Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis).
    In: Medical Letter on the CDC & FDA, 2023-12-25, S. 953-953
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Reports Outline Cancer Research from Kyushu University Hospital (Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy).
    In: Immunotherapy Weekly, 2023-12-14, S. 729-729
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    New Head and Neck Cancer Findings from Gifu University Reported (Comprehensive Genome Profile Testing In Head and Neck Cancer).
    In: Cancer Weekly, 2023-12-05, S. 653-653
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Research from Technical University Munich (TU Munich) Yields New Data on Polyomavirus (An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy).
    In: Immunotherapy Weekly, 2023-11-07, S. 1402-1402
    serialPeriodical
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -